Trastuzumab vs Valganciclovir

## Trastuzumab vs Valganciclovir: Overview

This comparison examines the pharmacological differences between **Trastuzumab** and **Valganciclovir**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Trastuzumab — 28 days; Valganciclovir — N/A.

## Chemical Properties

**Type**: Trastuzumab — Antibody; Valganciclovir — Small molecule.